BIT 5.26% 2.0¢ biotron limited

whats the second generation backup drug, page-2

  1. 789 Posts.
    lightbulb Created with Sketch. 144
    In the outlook section , it has lumped completion of HIV trial into the mid 2013 completion.

    I hope this is not another delay that goes against previous guidance of end of 2012.

    I liked the flow chart showing how bit225 tackles the HCV virus cells.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.